Skip to content

Clinical trials

Phase 2 Multiple Sclerosis trials in Denmark

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Multiple Sclerosis Phase: Phase 2 Country / region: Denmark Clear all

14 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20061
20071
20091
20101
20113
20181
20221
20241
20252
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed8
Recruiting2
Unknown status2
Active, not recruiting1
Not yet recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Rigshospitalet, Denmark4
GlaxoSmithKline2
Danish Multiple Sclerosis Hospitals1
Lars Hvid1
Merck KGaA, Darmstadt, Germany1
Novartis1
Tomas Olsson1
University Medical Center Groningen1
University of Aarhus1
Zenas BioPharma (USA), LLC1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Multiple Sclerosis14
Multiple Sclerosis, Chronic Progressive3
Multiple Sclerosis, Relapsing-Remitting3
Amyotrophic Lateral Sclerosis1
Fatigue1
Inflammation1
Major Depressive Disorder1
Pulmonary Disease, Chronic Obstructive1

Trials

Showing 1 to 14 of 14. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.